...
首页> 外文期刊>Cancer discovery. >GATA3-Controlled Nucleosome Eviction Drives MYC Enhancer Activity in T-cell Development and Leukemia
【24h】

GATA3-Controlled Nucleosome Eviction Drives MYC Enhancer Activity in T-cell Development and Leukemia

机译:GATA3控制的核心驱逐推动T细胞发育和白血病中的MYC增强剂活性

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Long-range enhancers govern the temporal and spatial control of gene expression; however, the mechanisms that regulate enhancer activity during normal and malignant development remain poorly understood. Here, we demonstrate a role for aberrant chromatin accessibility in the regulation of MYC expression in T-cell lymphoblastic leukemia (T-ALL). Central to this process, the NOTCH1-MYC enhancer (N-Me), a long-range T cell-specific MYC enhancer, shows dynamic changes in chromatin accessibility during T-cell specification and maturation and an aberrant high degree of chromatin accessibility in mouse and human T-ALL cells. Mechanistically, we demonstrate that GATA3-driven nucleosome eviction dynamically modulates N-Me enhancer activity and is strictly required for NOTCH1-induced T-ALL initiation and maintenance. These results directly implicate aberrant regulation of chromatin accessibility at oncogenic enhancers as a mechanism of leukemic transformation.
机译:远程增强剂控制基因表达的时间和空间控制; 然而,调节正常和恶性肿瘤期间增强剂活性的机制仍然明白很差。 在这里,我们证明了在T细胞淋巴细胞白血病(T-All)中MyC表达调节中的异常染色质可用的作用。 该过程中的核心,Notch1-Myc增强剂(N-ME),远程T细胞特异性MyC增强剂,显示出T细胞规格和成熟期间的染色质取证性的动态变化以及小鼠中的多种染色质的染色质可接受性 和人t-所有细胞。 机械地,我们证明了GATA3驱动的核心驱逐动态调节N-ME增强剂活性,并且严格需要NOTCH1诱导的T-all启动和维护。 这些结果直接暗示致癌增强剂的染色质可用性的异常调节作为白血动激素的机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号